FLOMICS BIOTECH

Flomics is developing a multi-purpose liquid biopsy, dynamic and capable of detecting multiple complex diseases, such as cancer, even before the first symptoms appear. Our blood-test combines optimized plasma cell-free RNA (cfRNA) profiling, based on Next-generation sequencing (NGS), with state-of-the-art machine learning data analysis implemented in the cloud to detect warning signs in an accurate, fast and minimally invasive way, before it?s too late. Everything out of a standard blood sample.